Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Ulldemolins

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Biotechnology|May 11, 2011
The relevance of drug volume of distribution in antibiotic dosingMarta Ulldemolins, Jordi Rello
Current Opinion in Critical Care|August 5, 2025
Nosocomial sepsis: how to reconcile immediate broad-spectrum therapy with minimal ecological pressure and healthcare costMarta Ulldemolins, Josep Mensa, Alex Soriano
Medicina Clinica|December 22, 2009
[Pharmacologic measures for the prevention of mechanical ventilation-associated pneumonia]Marta Ulldemolins, Marcos I Restrepo, Jordi Rello
Infectious Disease Clinics of North America|August 12, 2009
Management of ventilator-associated pneumoniaEmili Diaz, Marta Ulldemolins, Thiago Lisboa, et al.
Intensive Care Medicine|October 21, 2025
Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author's replyManuel Colmenero, Jason A Roberts, Jeffrey Lipman, et al.
Chest|May 5, 2011
Antibiotic dosing in multiple organ dysfunction syndromeMarta Ulldemolins, Jason A Roberts, Jeffrey Lipman, et al.
Critical Care Clinics|December 15, 2010
Appropriateness is criticalMarta Ulldemolins, Xavier Nuvials, Mercedes Palomar, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2010
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokineticsMarta Ulldemolins, Jason A Roberts, Steven C Wallis, et al.
Clinical Pharmacokinetics|December 15, 2010
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patientsMarta Ulldemolins, Jason A Roberts, Jordi Rello, et al.
International Journal of Antimicrobial Agents|March 27, 2025
Exploring the subcutaneous route for dalbavancin administration in a long-term suppressive therapy of orthopaedic device-related infectionPaula Pons-Oltra, Eva Benavent, Miriam Maireles, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Biotechnology|May 11, 2011
The relevance of drug volume of distribution in antibiotic dosingMarta Ulldemolins, Jordi Rello
Current Opinion in Critical Care|August 5, 2025
Nosocomial sepsis: how to reconcile immediate broad-spectrum therapy with minimal ecological pressure and healthcare costMarta Ulldemolins, Josep Mensa, Alex Soriano
Medicina Clinica|December 22, 2009
[Pharmacologic measures for the prevention of mechanical ventilation-associated pneumonia]Marta Ulldemolins, Marcos I Restrepo, Jordi Rello
Infectious Disease Clinics of North America|August 12, 2009
Management of ventilator-associated pneumoniaEmili Diaz, Marta Ulldemolins, Thiago Lisboa, et al.
Intensive Care Medicine|October 21, 2025
Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author's replyManuel Colmenero, Jason A Roberts, Jeffrey Lipman, et al.
Chest|May 5, 2011
Antibiotic dosing in multiple organ dysfunction syndromeMarta Ulldemolins, Jason A Roberts, Jeffrey Lipman, et al.
Critical Care Clinics|December 15, 2010
Appropriateness is criticalMarta Ulldemolins, Xavier Nuvials, Mercedes Palomar, et al.
The Journal of Antimicrobial Chemotherapy|June 10, 2010
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokineticsMarta Ulldemolins, Jason A Roberts, Steven C Wallis, et al.
Clinical Pharmacokinetics|December 15, 2010
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patientsMarta Ulldemolins, Jason A Roberts, Jordi Rello, et al.
International Journal of Antimicrobial Agents|March 27, 2025
Exploring the subcutaneous route for dalbavancin administration in a long-term suppressive therapy of orthopaedic device-related infectionPaula Pons-Oltra, Eva Benavent, Miriam Maireles, et al.
Pageof 4